Biotech & MedTech



Latest Comments
image_pdfimage_print

David Regan of Sona Nanotech on bringing their rapid saliva Covid-19 test to the market

In a recent InvestorIntel interview, Tracy Weslosky spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA | OTCQB: SNANF) about their […]


Jack Lifton interviews David Regan of Sona Nanotech on its breakthrough, gold nanorod, medical technology

In a recent InvestorIntel interview, Jack Lifton spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA | OTCQB: […]


Thomas Smeenk on Hemostemix products for Your Fountain of Youth

In a recent InvestorIntel interview, Tracy Weslosky spoke with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc. (TSXV: HEM | […]


Sona Nanotech’s gold nanorods improve cancer treatments

For virtually everyone on the planet, cancer is a four letter word. One has to have a pretty rosy outlook […]


Drolet Stock Notes on Hemostemix: Regenerating Stem Cells to Treat Diseases

Mario Drolet, President of MI3 Communications Financières Inc. (MI3), released his Drolet Stock Notes on Hemostemix Inc. (TSXV: HEM | […]


Built on arguably one of the greatest medical breakthroughs of our time, Hemostemix has ‘your fountain of youth’…

Stem cell therapy is potentially one of the greatest medical breakthroughs of our time. It is truly amazing that we […]


Valeo Pharma is cashed up and ready to expand as COVID restrictions end

Are we starting to see the beginning of the end of COVID’s reign of terror over humanity? I certainly hope […]


Drolet Stock Notes on IMV Inc.: A clinical stage company developing a first-in-class T cell targeted immune therapy for cancer

Mario Drolet, President of MI3 Communications Financières Inc. (MI3), released his Drolet Stock Notes on IMV Inc. (NASDAQ: IMV | […]


Brent Willis of Voyageur Pharmaceuticals discusses the high IRR and NPV in its recent PEA

In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV: VM) about […]


The light at the end of the tunnel for Awakn Life Sciences addiction treatment by Psychedelic therapeutics

As an investor, I like to look for companies that have tremendous leverage to success. I often write about junior […]